Oracle’s Hardware Business Predicted to Rebound and 4 Stock Analyses Sparking Chatter

Orexigen Therapeutics, Inc. (NASDAQ:OREX): Current Price: $5.75

Takeda, which has agreed to market Orexigen’s anti-obesity drug, gained FDA approval for its type 2 diabetes treatment, influencing JMP Securities to view the development as positive for Orexigen. The firm has stated that it believe that the approval makes Takeda more likely to dedicate resources to cardiometabolic diseases in general. JMP Securities keeps its Outperform rating on the stock.